Novaliq collaborates with leading scientific partners
Prof. Dr. med. Claus Cursiefen and Prof. Dr. med. Philipp Steven in the field of ophthalmic drug delivery for the anterior segment of the eye with special focus on dry eye disease.
Prof. Heping Xu, MD, PhD, in the field of retina diseases.
Dr. Ilva Rupenthal in the field of drug delivery technologies and ocular therapeutics.
Prof. Dr. med. Johannes Wohlrab in the field of penetration and dermatology.
Prof. Dr. Wolfgang Frieß in the field of protein formulation.
Prof. Gordon Tiddy and Dr. Robin Curtis in the field of basic research in formulation sciences.